Aprinoia

Developer of diagnostics and therapeutics for neurodegenerative disorders

placeTaipei, Taipei, Taiwan calendar_todayFounded 2015 groups15 employees language aprinoia.com

Registered entities

Investor mix

12 investors on record; lead investors include Daiwa Corporate Investment, KTB Network, Yantai Dongcheng Biochemicals.

Investor typeCountShare
Venture capital433%
Private equity325%
Other / undisclosed542%
Coming soon